agilon health Reports First Quarter 2021 Results

Go back to agilon health Reports First Quarter 2021 Results

agilon health Inc (AGL) PT Raised to $43 at BofA Securities

May 27, 2021 8:26 AM EDT

BofA Securities analyst Kevin Fischbeck raised the price target on agilon health Inc (NYSE: AGL) to $43.00 (from $41.00) while maintaining a Buy rating.

Raising ests as strong Q1 should flow through... More

Agilon Health Inc. (AGL) Reports Q1 Loss of $0.04, Revenues Beat

May 26, 2021 4:34 PM EDT

Agilon Health Inc. (NYSE: AGL) reported Q1 EPS of ($0.04), versus ($0.02) reported last year. Revenue for the quarter came in at $413.1 million, versus $291.05 million reported last year.

First Quarter 2021 Results:

Total revenue of $413 million increased 42% from 2020 and would have increased approximately 50% including a recently completed group Medicare Advantage (MA) contract that is retroactive to January... More